Literature DB >> 27956442

Multiple sclerosis, a treatable disease.

Anisha Doshi1, Jeremy Chataway2.   

Abstract

This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key features that can be useful in the clinic. We comment on the diagnostic criteria and review the main subtypes of MS, including clinically isolated syndrome, relapsing remitting MS, secondary progressive MS and primary progressive MS. Although the underlying aetiology of MS is still not known, we summarise those with most evidence of association. Finally, we aim to present treatment strategies for managing the acute relapse, disease-modifying therapies and MS symptoms. This review highlights that progressive MS is an area where there is currently a paucity of available disease-modifying treatments and this will be a major focus for future development. © Royal College of Physicians 2016. All rights reserved.

Entities:  

Keywords:  Diagnostic criteria; epidemiology; multiple sclerosis; progressive multiple sclerosis; treatments

Mesh:

Year:  2016        PMID: 27956442      PMCID: PMC6329568          DOI: 10.7861/clinmedicine.16-6-s53

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  19 in total

1.  Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.

Authors:  Joanie Thelen; Valeriy Zvonarev; Sarah Lam; Crystal Burkhardt; Sharon Lynch; Jared Bruce
Journal:  Mo Med       Date:  2021 May-Jun

Review 2.  Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: A systematic review and meta-analysis.

Authors:  Diulle Spat Peres; Patrícia Rodrigues; Fernanda Tibolla Viero; Julia Maria Frare; Sabrina Qader Kudsi; Graziela Moro Meira; Gabriela Trevisan
Journal:  Brain Behav Immun Health       Date:  2022-07-06

Review 3.  Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health.

Authors:  Jessica Maiuolo; Vincenzo Musolino; Micaela Gliozzi; Cristina Carresi; Federica Scarano; Saverio Nucera; Miriam Scicchitano; Francesca Oppedisano; Francesca Bosco; Roberta Macri; Ernesto Palma; Carolina Muscoli; Vincenzo Mollace
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

4.  Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome.

Authors:  Qiling Ji; Huiqing Dong; Hangil Lee; Zheng Liu; Yanna Tong; Kenneth Elkin; Yazeed Haddad; Xiaokun Geng; Yuchuan Ding
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

Review 5.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

6.  Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs.

Authors:  Sarah E Fiedler; Joshua D George; Haley N Love; Edward Kim; Rebecca Spain; Dennis Bourdette; Sonemany Salinthone
Journal:  J Syst Integr Neurosci       Date:  2017-06-17

Review 7.  An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis.

Authors:  Marzia Fronza; Lorena Lorefice; Jessica Frau; Eleonora Cocco
Journal:  Drug Des Devel Ther       Date:  2021-05-11       Impact factor: 4.162

8.  Comprehensive catwalk gait analysis in a chronic model of multiple sclerosis subjected to treadmill exercise training.

Authors:  Danielle Bernardes; Alexandre Leite Rodrigues Oliveira
Journal:  BMC Neurol       Date:  2017-08-22       Impact factor: 2.474

9.  Patient-Reported Disease-Modifying Therapy Adherence in the Clinic: A Reliable Metric?

Authors:  Devon S Conway; Maria Cecilia Vieira; Nicolas R Thompson; Kaila N Parker; Xiangyi Meng; Robert J Fox
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-05-23

10.  Motor Imagery as a Function of Disease Severity in Multiple Sclerosis: An fMRI Study.

Authors:  Andrea Tacchino; Catarina Saiote; Giampaolo Brichetto; Giulia Bommarito; Luca Roccatagliata; Christian Cordano; Mario A Battaglia; Gian L Mancardi; Matilde Inglese
Journal:  Front Hum Neurosci       Date:  2018-01-11       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.